Hussman Strategic Advisors, Inc. Charles River Laboratories International, Inc. Transaction History

Hussman Strategic Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 31, 2020	SELL	$126.05 - $152.76 $31,512 - $38,190	-250 Closed	0 $0
Q3 2019 Oct 31, 2019	BUY	$125.07 - $143.67 $31,267 - $35,917	250 New	250 $33,000
Q2 2019 Jul 31, 2019	SELL	$123.4 - $148.55 $1.85 Million - $2.23 Million	-15,000 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$104.82 - $146.73 $1.05 Million - $1.47 Million	-10,000 Reduced 40.0%	15,000 $2.18 Million
Q4 2018 Feb 01, 2019	BUY	$105.09 - $137.23 $2.63 Million - $3.43 Million	25,000 New	25,000 $2.83 Million

706

53.9M

122K

239K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $7.85B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.